BIX-01294 Sensitizes Renal Cancer Caki Cells to TRAIL-induced Apoptosis Through Downregulation of Survivin Expression and Upregulation of DR5 Expression

Overview

Journal Cell Death Discov

Date 2018 Mar 14

PMID 29531826

Citations 11

Authors

Seon Min Woo

Seung Un Seo

Kyoung-Jin Min

Taeg Kyu Kwon

Affiliations

Soon will be listed here.

Abstract

BIX-01294 (BIX), a G9a histone methyltransferase inhibitor, has been reported for its anti-proliferative and anticancer activities against various cancer cell lines. In this study, we investigated whether BIX could sensitize TRAIL-mediated apoptosis in various cancer cells. Combined treatment with BIX and TRAIL markedly induced apoptosis in human renal carcinoma (Caki, ACHN, and A498), breast carcinoma (MCF-7), and lung carcinoma (A549) cells. In contrast, BIX and TRAIL co-treatment did not induce apoptosis in normal cells, specifically mouse kidney cell (TCMK-1) and human skin fibroblast (HSF). BIX downregulated protein expression levels of XIAP and survivin at the post-translational level. Overexpression of survivin markedly blocked combined BIX and TRAIL treatment-induced apoptosis, but XIAP had no effect. Furthermore, BIX induced upregulation of DR5 expression at the transcriptional levels, and knockdown of DR5 expression using small interfering RNAs (siRNAs) markedly attenuated BIX and TRAIL-induced apoptosis. Interestingly, siRNA-mediated G9a histone methyltransferase knockdown also enhanced TRAIL-induced apoptosis in Caki cells. However, knockdown of G9a did not change expression levels of XIAP, survivin, and DR5. Therefore, BIX-mediated TRAIL sensitization was independent of histone methyltransferase G9a activity. Taken together, these results suggest that BIX facilitates TRAIL-mediated apoptosis via downregulation of survivin and upregulation of DR5 expression in renal carcinoma Caki cells. ▶ BIX facilitates TRAIL-mediated apoptosis in human renal carcinoma Caki cells. ▶ Downregulation of survivin contributes to BIX plus TRAIL-induced apoptosis. ▶ Upregulation of DR5 is involved in BIX plus TRAIL-mediated apoptosis. ▶ BIX-mediated TRAIL sensitization is independent of ROS production.

Citing Articles

Inhibition of USP2 Enhances TRAIL-Mediated Cancer Cell Death through Downregulation of Survivin.

Lee T, Woo S, Seo S, Kim S, Park J, Chang Y Int J Mol Sci. 2023; 24(16).

PMID: 37628997 PMC: 10454696. DOI: 10.3390/ijms241612816.

H3 histone methylation landscape in male urogenital cancers: from molecular mechanisms to epigenetic biomarkers and therapeutic targets.

Burlibasa L, Nicu A, Chifiriuc M, Medar C, Petrescu A, Jinga V Front Cell Dev Biol. 2023; 11:1181764.

PMID: 37228649 PMC: 10203431. DOI: 10.3389/fcell.2023.1181764.

The role of histone methylation in renal cell cancer: an update.

Hou Y, Yuan Y, Li Y, Wang L, Hu J, Liu X Mol Biol Rep. 2022; 50(3):2735-2742.

PMID: 36575323 DOI: 10.1007/s11033-022-08124-3.

Improving TRAIL-induced apoptosis in cancers by interfering with histone modifications.

Zhang B, Chen D, Dekker F, Quax W Cancer Drug Resist. 2022; 3(4):791-803.

PMID: 35582230 PMC: 8992553. DOI: 10.20517/cdr.2020.58.

The Role and Mechanism of Lysine Methyltransferase and Arginine Methyltransferase in Kidney Diseases.

Zhou X, Chen H, Li J, Shi Y, Zhuang S, Liu N Front Pharmacol. 2022; 13:885527.

PMID: 35559246 PMC: 9086358. DOI: 10.3389/fphar.2022.885527.

References

Seo B, Min K, Woo S, Choe M, Choi K, Lee Y . Inhibition of Cathepsin S Induces Mitochondrial ROS That Sensitizes TRAIL-Mediated Apoptosis Through p53-Mediated Downregulation of Bcl-2 and c-FLIP. Antioxid Redox Signal. 2016; 27(4):215-233. DOI: 10.1089/ars.2016.6749. View

Chen J, Chou C, Chang Y, Chen C . Proteasome inhibitors enhance TRAIL-induced apoptosis through the intronic regulation of DR5: involvement of NF-kappa B and reactive oxygen species-mediated p53 activation. J Immunol. 2008; 180(12):8030-9. DOI: 10.4049/jimmunol.180.12.8030. View

An Y, Hwang J, Lee J, Kim Y . Cornus officinalis Methanol Extract Upregulates Melanogenesis in Melan-a Cells. Toxicol Res. 2015; 31(2):165-72. PMC: 4505347. DOI: 10.5487/TR.2015.31.2.165. View

Cui J, Sun W, Hao X, Wei M, Su X, Zhang Y . EHMT2 inhibitor BIX-01294 induces apoptosis through PMAIP1-USP9X-MCL1 axis in human bladder cancer cells. Cancer Cell Int. 2015; 15(1):4. PMC: 4326523. DOI: 10.1186/s12935-014-0149-x. View

Wu G, Burns T, McDonald 3rd E, Jiang W, Meng R, Krantz I . KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet. 1997; 17(2):141-3. DOI: 10.1038/ng1097-141. View

Kubicek S, OSullivan R, August E, Hickey E, Zhang Q, Teodoro M . Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. Mol Cell. 2007; 25(3):473-81. DOI: 10.1016/j.molcel.2007.01.017. View

Tachibana M, Sugimoto K, Nozaki M, Ueda J, Ohta T, Ohki M . G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev. 2002; 16(14):1779-91. PMC: 186403. DOI: 10.1101/gad.989402. View

Wang S, El-Deiry W . TRAIL and apoptosis induction by TNF-family death receptors. Oncogene. 2003; 22(53):8628-33. DOI: 10.1038/sj.onc.1207232. View

Abdulghani J, El-Deiry W . TRAIL receptor signaling and therapeutics. Expert Opin Ther Targets. 2010; 14(10):1091-108. DOI: 10.1517/14728222.2010.519701. View

10.

Park S, Yi H, Suh N, Park Y, Koh J, Jeong S . Inhibition of EHMT2/G9a epigenetically increases the transcription of Beclin-1 via an increase in ROS and activation of NF-κB. Oncotarget. 2016; 7(26):39796-39808. PMC: 5129971. DOI: 10.18632/oncotarget.9290. View

11.

Ravid T, Hochstrasser M . Diversity of degradation signals in the ubiquitin-proteasome system. Nat Rev Mol Cell Biol. 2008; 9(9):679-90. PMC: 2606094. DOI: 10.1038/nrm2468. View

12.

Jung K, Min K, Bae J, Kwon T . Carnosic acid sensitized TRAIL-mediated apoptosis through down-regulation of c-FLIP and Bcl-2 expression at the post translational levels and CHOP-dependent up-regulation of DR5, Bim, and PUMA expression in human carcinoma caki cells. Oncotarget. 2015; 6(3):1556-68. PMC: 4359314. DOI: 10.18632/oncotarget.2727. View

13.

Zhang L, Fang B . Mechanisms of resistance to TRAIL-induced apoptosis in cancer. Cancer Gene Ther. 2004; 12(3):228-37. DOI: 10.1038/sj.cgt.7700792. View

14.

Hua K, Wang M, Chen M, Wei L, Chen C, Ko C . The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis. Mol Cancer. 2014; 13:189. PMC: 4260797. DOI: 10.1186/1476-4598-13-189. View

15.

Kim J, Kim E, Park S, Lim J, Kwon T, Choi K . Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation. J Cell Biochem. 2008; 105(6):1386-98. DOI: 10.1002/jcb.21958. View

16.

Zhang Y, Zhang B . TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5. Mol Cancer Res. 2008; 6(12):1861-71. DOI: 10.1158/1541-7786.MCR-08-0313. View

17.

Dilshara M, Kang C, Choi Y, Kim G . Mangiferin inhibits tumor necrosis factor-α-induced matrix metalloproteinase-9 expression and cellular invasion by suppressing nuclear factor-κB activity. BMB Rep. 2015; 48(10):559-64. PMC: 4911182. DOI: 10.5483/bmbrep.2015.48.10.003. View

18.

Kim Y, Kim Y, Kim D, Lee J, Song J, Kim H . BIX-01294 induces autophagy-associated cell death via EHMT2/G9a dysfunction and intracellular reactive oxygen species production. Autophagy. 2013; 9(12):2126-39. DOI: 10.4161/auto.26308. View

19.

Ke X, Zhang D, Zhu S, Xia Q, Xiang Z, Cui H . Inhibition of H3K9 methyltransferase G9a repressed cell proliferation and induced autophagy in neuroblastoma cells. PLoS One. 2014; 9(9):e106962. PMC: 4157855. DOI: 10.1371/journal.pone.0106962. View

20.

Kondo Y, Shen L, Ahmed S, Boumber Y, Sekido Y, Haddad B . Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells. PLoS One. 2008; 3(4):e2037. PMC: 2323574. DOI: 10.1371/journal.pone.0002037. View